Touchstone
Last syncOct 31, 2026, 6:54 PM ET

MDT

Medtronic Plc Health Care Electromedical & Electrotherapeutic Apparatus S&P 500Russell 3000
$96.54Close $123.6BMarket cap $73.09 – $102.8152-week range Nov 17, 2026Next report

Highlights

Strengths

  • Earnings growing EPS +42% year on year

Cautions

  • Not in an uptrend 5 of 8 trend conditions

Price

Filing Results Screen pick 52-week high and low Adjusted prices

Key figures

FY to Apr 24, 2026 · filed Sep 3, 2026
Off 12-month high 6%
1wk up 1.2% price change
1mo up 11.9% price change
12-month return up 9% market up 11% · its own down 3%
F-score 7 / 9 Strong
Altman Z 3.01 Low risk
P/E 25742203.1× price / earnings
PEG 8,236,292.27 P/E / EPS growth
P/B 2.5× price / book
Earnings yield up 4.4% EBIT / enterprise value
Cheaper than 61% of the market · cheap
Revenue growth up 8% year on year
EPS growth up 42% latest quarter
Sales growth up 14% latest quarter · +4 pts
ROE 0% return on equity
Free cash margin up 15% $5.4B FCF
D/E 0.53 long-term debt / equity
Net debt / EBITDA 2.6×
Interest cover 16.9×EBIT / interest
Piotroski tests
  • took on more long-term debt
  • gross margin narrowed
  • profitable on its assets
  • generating cash from operations
  • profitability improving
  • profits backed by cash
  • short-term liquidity improved
  • no new shares issued
  • assets working harder

Trade setup

ATR% 2.3% $2.24 a day · 2×ATR $92.05
RS 62 / 99 vs the universe
Trend 5 / 8 150-day under the 200-day, 200-day not rising, RS under 70
Relative volume 0.5× vs 50-day average
Up/down volume 1.30 50 sessions
Implied move 5.1% by Nov 20, 2026 · report Nov 17, 2026
Trend template · 5 of 8
  • Price above the 150 and 200-day averages: passes
  • 150-day average above the 200-day: fails
  • 200-day average rising for a month: fails
  • 50-day average above the 150 and 200-day: passes
  • Price above the 50-day average: passes
  • At least 30% above the 52-week low: passes
  • Within 25% of the 52-week high: passes
  • RS rank 70 or higher: fails

Screen verdict

Did not qualify for any screen.

Warning signs

none flagged
  • No restatement or impairment
  • Equity positive
  • Interest covered
  • No material dilution
  • Profits tracking cash
  • Margins and revenue not shrinking
Last reported Sep 1, 2026
Results reaction Sep 1, 2026+2% vs market2 sessions after results
Options $1.8M28.3% IV · activity

Financials

6 fiscal years · from filings
Revenue What customers paid the company over its fiscal year, before any cost, as filed in its annual report. The change is against the year before. Methodology $36.4B +8% on FY2025
$0 $50B FY21 FY22 FY23 FY24 FY25 FY26 FY2021 · $30.1B FY2022 · $31.7B FY2023 · $31.2B FY2024 · $32.4B FY2025 · $33.5B FY2026 · $36.4B
Net income Profit left after every cost, interest and tax for the year. A column below the line is a loss. Methodology $4,801 +3% on FY2025
$0 $5B FY21 FY22 FY23 FY24 FY25 FY26 FY2021 · $3.6B FY2022 · $5,039 FY2023 · $3,758 FY2024 · $3,676 FY2025 · $4,662 FY2026 · $4,801
Free cash flow Cash from running the business less what it spent on equipment and buildings: the cash a year actually left behind, which profit alone does not show. Not shown for banks and insurers, whose cash moves with their loans. Methodology $5.4B +5% on FY2025
$0 $10B FY21 FY22 FY23 FY24 FY25 FY26 FY2021 · $4.9B FY2022 · $6.0B FY2023 · $4.6B FY2024 · $5.2B FY2025 · $5.2B FY2026 · $5.4B
Margins Each as a share of revenue. Gross: left after the direct cost of what was sold. Net: left after every cost. Free cash: free cash flow over revenue. A margin rising over years means the business keeps more of each dollar it sells. Methodology
  • Gross 65%
  • Net 0%
  • Free cash 15%
0% 100% FY21 FY22 FY23 FY24 FY25 FY26 FY2021 · Gross 65% · Net 12% · Free cash 16% FY2022 · Gross 68% · Net 0% · Free cash 19% FY2023 · Gross 66% · Net 0% · Free cash 15% FY2024 · Gross 65% · Net 0% · Free cash 16% FY2025 · Gross 65% · Net 0% · Free cash 15% FY2026 · Gross 65% · Net 0% · Free cash 15%
Cash and long-term debt Cash on the balance sheet at the year's end beside debt due after a year. Net cash is cash less that debt; net debt is the shortfall. Debt some filers do not tag shows as a gap, not as zero. Methodology $24.2B net debt
  • Cash
  • Long-term debt
$0 $50B FY21 FY22 FY23 FY24 FY25 FY26 FY2021 · Cash $3.6B · Long-term debt $26.4B FY2022 · Cash $3.7B · Long-term debt $20.4B FY2023 · Cash $1.5B · Long-term debt $24.3B FY2024 · Cash $1.3B · Long-term debt $23.9B FY2025 · Cash $2.2B · Long-term debt $25.6B FY2026 · Cash $1.9B · Long-term debt $26.2B
Shares outstanding Shares in issue at the year's end. A rising count means each share owns a smaller slice of the company (stock pay, share sales); a falling one, buybacks. The chart's scale is fitted to the count, so a small change looks large: read the percentage. Methodology 1.28bn -4.8% since FY2021
1.35bn 1.28bn FY21 FY22 FY23 FY24 FY25 FY26 FY2021 · 1.35bn FY2022 · 1.33bn FY2023 · 1.33bn FY2024 · 1.31bn FY2025 · 1.28bn FY2026 · 1.28bn
  FY2021Apr 30, 2021 FY2022Apr 29, 2022 FY2023Apr 28, 2023 FY2024Apr 26, 2024 FY2025Apr 25, 2025 FY2026Apr 24, 2026
Revenue $30.1B $31.7B $31.2B $32.4B $33.5B $36.4B
Gross margin 65% 68% 66% 65% 65% 65%
Operating income $4.5B $5.8B $5.5B $5.1B $6.0B $6.5B
Net income $3.6B $5,039 $3,758 $3,676 $4,662 $4,801
Net margin 12% 0% 0% 0% 0% 0%
Earnings per share $2.66 $0.00 $0.00 $0.00 $0.00 $0.00
Free cash flow $4.9B $6.0B $4.6B $5.2B $5.2B $5.4B
Free cash margin 16% 19% 15% 16% 15% 15%
Cash $3.6B $3.7B $1.5B $1.3B $2.2B $1.9B
Long-term debt $26.4B $20.4B $24.3B $23.9B $25.6B $26.2B
Shareholders' equity $51.4B $52.6B $51.5B $50.2B $48.0B $49.5B
Shares outstanding 1.35bn 1.33bn 1.33bn 1.31bn 1.28bn 1.28bn

Next report

Nov 17, 2026

Expected move The move, either way, the option market prices in through the next scheduled report: the at-the-money straddle for the first expiry that contains it, over the price. It includes the days around the report, so it slightly overstates the report alone. Methodology ±5.1% $92 – $102 by Nov 20, 2026
Usual move The median, over the company's last four reports, of how far the stock moved either way from the close before the filing to the close of the session after it. Methodology ±3.0% last 4: +1.7% · +11.1% · -1.0% · +4.2%
Expected against usual The move the options price through this report over the move the last four reports delivered. Above 1 the event is priced bigger than the company's own record; below 1, smaller. A price, not a forecast: it says what protection through the report costs, not which way the stock will go. Methodology Bigger than usual 1.7× the usual move

What options price now

Expected 1-month range The at-the-money straddle for the expiry nearest a month out, as a share of the price: the move, either way, the option market is pricing by then. The range is the price plus and minus that move; the stock ends inside it a little more often than not. Methodology
$91 – $102 ±5.4% by Nov 27, 2026
Swings expected vs recent The daily swings the options are priced for (implied volatility) against the swings the stock actually had over the last 20 sessions (realised volatility). Bigger means options charge for more movement than the stock has been delivering; smaller, less. On a contract row, that contract's own implied volatility over the stock's realised. Methodology
About the same 28.3% priced · 29.1% recent
Next month vs later At-the-money implied volatility for 8-45 day expiries over 46-90 day ones: whether options price the coming month as choppier or calmer than the two after it. Ahead of a report it usually reads choppier, and the extra comes out once the report is out. Methodology
About the same
Crash protection What options that pay off in a fall cost against options that pay off in a rise (the 25-delta skew), compared with this company's own normal - the median of its stored nightly readings, once there are 20 - and with five sessions ago. Protection costs a little more than upside on most shares. More than usual means readers of the chain are paying up to insure against a drop; it does not say which way the stock will go. Methodology
past week: costs more
Positioning
Premium traded
$1.8M calls $568,591 · puts $1.3M · latest session
Puts against calls, by premium Money spent on puts divided by money spent on calls. Measured in dollars rather than contracts on purpose: counting contracts treats a hundred cheap lottery tickets as more meaningful than one large position, which is backwards. Methodology
2.24× +1.88 over the week
Open interest added The change over five sessions in option positions left open overnight, calls and puts. A rise means positions were added. It cannot say whether they were bought or sold, so more calls is not a vote for a rise: a call is as often sold against shares already held. Methodology
calls -598 · puts -3.39k past week

For options traders: ATM IV 28.3% (+1.8% 1w) · 1m ÷ 3m IV 0.98 · 25Δ skew 2.7 pts · Net GEX $17.4M

Most traded contracts

No contract passed the liquidity filters this week.

Filings

SEC EDGAR
FiledReportPeriod to Lag
Sep 3, 2026 Quarterly ↗ Jul 31, 2026 34d
Jun 18, 2026 Annual ↗ Apr 24, 2026 55d
Feb 24, 2026 Quarterly ↗ Jan 23, 2026 32d
Nov 25, 2025 Quarterly ↗ Oct 24, 2025 32d
Aug 26, 2025 Quarterly ↗ Jul 25, 2025 32d
Jun 20, 2025 Annual ↗ Apr 25, 2025 56d
Feb 25, 2025 Quarterly ↗ Jan 24, 2025 32d
Nov 26, 2024 Quarterly ↗ Oct 25, 2024 32d
Aug 27, 2024 Quarterly ↗ Jul 26, 2024 32d
Jun 20, 2024 Annual ↗ Apr 26, 2024 55d
Feb 27, 2024 Quarterly ↗ Jan 26, 2024 32d
Nov 30, 2023 Quarterly ↗ Oct 27, 2023 34d

Current reports

FiledDisclosed
Oct 19, 2026 Director or officer change · Shareholder vote · Regulation FD ↗
Sep 17, 2026 Other events ↗
Sep 1, 2026 Results ↗
Jun 3, 2026 Results ↗
May 18, 2026 Director or officer change ↗
Apr 27, 2026 Regulation FD ↗
Mar 24, 2026 Regulation FD ↗
Feb 17, 2026 Results ↗
Nov 18, 2025 Results ↗
Nov 3, 2025 Director or officer change ↗
Oct 21, 2025 Charter or bylaws · Shareholder vote ↗
Sep 29, 2025 Material agreement · Other events ↗